Definition of a Family of Nonmobile Colistin Resistance (NMCR‐1) Determinants Suggests Aquatic Reservoirs for MCR‐4

Advanced Science - Tập 6 Số 11 - 2019
Huimin Zhang1,2, Wenhui Wei2, Man Huang2, Zeeshan Umar2, Youjun Feng2
1Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA
2Department of Pathogen Biology & Microbiology and Department of General Intensive Care Unit of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310058, China

Tóm tắt

AbstractPolymyxins, a family of cationic antimicrobial peptides, are recognized as a last‐resort clinical option used in the treatment of lethal infections with carbapenem‐resistant pathogens. A growing body of mobile colistin resistance (MCR) determinants renders colistin ineffective in the clinical and human sectors, posing a challenge to human health and food security. However, the origin and reservoir of the MCR family enzymes is poorly understood. Herein, a new family of nonmobile colistin resistance (from nmcr‐1 to nmcr‐1.8) from the aquatic bacterium Shewanella is reported. NMCR‐1 (541aa) displays 62.78% identity to MCR‐4. Genetic and structural analyses reveal that NMCR‐1 shares a similar catalytic mechanism and functional motifs, both of which are required for MCR action and its resultant phenotypic resistance to polymyxin. Phylogeny and domain‐swapping demonstrate that NMCR‐1 is a progenitor of MCR‐4 rather than MCR‐1/2. Additionally, the experiment of bacterial growth and viability reveals that NMCR‐1 promotes fitness cost as MCR‐1/4 does in the recipient Escherichia coli. In summary, the finding suggests that the aquatic bacterium Shewanella (and even its associated aquaculture) is a reservoir for MCR‐4 mobile colistin resistance.

Từ khóa


Tài liệu tham khảo

10.1016/S0140-6736(16)31079-0

O. N. J.London Review on Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations https://www.west‐info.eu/drug‐resistant‐infections‐could‐lead‐to‐10‐million‐extra‐deaths‐a‐year/amr‐review‐paper‐tackling‐a‐crisis‐for‐the‐health‐and‐wealth‐of‐nations_1/(accessed: December2014).

10.1371/journal.pmed.1002184

10.1093/jac/18.5.557

10.1016/S1473-3099(18)30119-1

10.1093/jac/dkw274

10.1016/j.tim.2018.02.006

10.1021/acsinfecdis.7b00201

10.1107/S2053230X17009669

10.2807/1560-7917.ES.2016.21.27.30280

10.1128/mBio.02317-17

10.1128/mBio.00625-17

10.1038/s41426-018-0124-z

10.1016/S1473-3099(15)00424-7

10.1360/N972016-01084

Zhou H. W., 2017, Antimicrob. Agents Chemother., 61, e00017

10.1128/AAC.00195-18

10.3201/eid2209.160692

10.1016/j.ijantimicag.2018.01.007

10.1186/s40168-017-0288-0

10.18632/oncotarget.12621

10.1128/mBio.00177-16

10.1371/journal.ppat.1005957

10.1016/S1473-3099(16)30528-X

10.1093/jac/dky262

10.3391/mbi.2017.8.4.09

10.1016/j.ebiom.2018.07.027

10.1128/AAC.00278-18

10.1093/jac/dkx327

10.1093/jac/dky272

10.1093/jac/dky111

10.2807/1560-7917.ES.2017.22.31.30589

10.1371/journal.pone.0193957

10.1016/j.ijantimicag.2018.03.022

10.2807/1560-7917.ES.2018.23.2.17-00821

10.1128/JCM.01562-17

10.1128/AAC.00649-18

10.2807/1560-7917.ES.2018.23.6.17-00672

10.1128/JB.185.11.3270-3277.2003

10.1016/j.scib.2018.07.017

10.1016/j.jmb.2013.06.029

10.1073/pnas.1612927114

10.1186/s12915-016-0303-0

10.1096/fj.201700705R

10.1074/jbc.RA117.000924

10.1038/s42003-018-0278-1

10.1128/AAC.00756-12

10.1073/pnas.1425007112

10.1371/journal.pgen.1007389

10.1093/jac/dkx225

10.1128/AAC.00129-17

10.1093/jac/dkx286

10.1021/acschembio.8b00116

10.1016/j.ijantimicag.2015.09.001

10.3389/fphar.2018.00419

10.1016/j.jgar.2018.06.005

10.1016/S2542-5196(18)30124-4

Sun J., 2016, Infect. Dis. Transl. Med., 2, 122

10.1128/AAC.01272-17

10.1093/jac/dkx538

Wang X., 2018, Antimicrob. Agents Chemother., 62, e02106

10.1128/mBio.01229-17

10.1128/mBio.01629-18

10.1073/pnas.0913451107

10.1128/IAI.01046-12

10.1074/jbc.M112.380212

10.1074/jbc.M111.321737

10.3109/1040841X.2012.726209

10.1038/nrmicro1947

10.1111/j.1469-0691.2005.01108.x

10.4269/ajtmh.13-0055

10.1007/s10096-017-2962-3

10.1128/AAC.00570-10

10.1128/AAC.49.8.3523-3525.2005

10.1128/AAC.01879-17

10.1128/AAC.00681-11

10.1038/s41467-017-02149-0

10.1038/s41564-018-0205-8

10.1080/21505594.2018.1462060

10.1111/mmi.14066

10.1002/mbo3.270

10.1111/j.1365-2958.2011.07564.x

10.3390/cosmetics4040039

10.1073/pnas.1001793107

10.1007/s00216-015-8631-4

10.1016/j.chroma.2012.12.072

10.1002/advs.201900034